Literature DB >> 20686358

Genetic immunization: bacteria as DNA vaccine delivery vehicles.

Pablo Daniel Becker1, Miriam Noerder, Carlos Alberto Guzmán.   

Abstract

The so-called DNA vaccination represents one of the most notable tools under development in the field of vaccinology. The concept of administering the gene coding for any given protective antigen and make responsible vaccinee's own cells to produce the protein appeals as too simple to be true. Indeed, the implementation of this approach for mass vaccination should overcome several bottlenecks, such as need of high dosages and poor immunogenicity. In this context, the use of live attenuated bacteria as delivery system for plasmid DNA has emerged as a promising alternative to overcome many of those pitfalls. In addition, this approach is not only amenable for mucosal administration, but allows to specifically target professional antigen presenting cells. This results in their transfection, as well as in their activation and maturation, due to their built-in adjuvant properties resulting from the stimulation of pattern recognition receptors. This chapter discusses the specific features that should be taken into consideration when designing a plasmid vector, current candidate bacterial carriers for DNA delivery and main safety issues.

Mesh:

Substances:

Year:  2010        PMID: 20686358     DOI: 10.4161/hv.4.3.6314

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  8 in total

Review 1.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

2.  Tc52 amino-terminal-domain DNA carried by attenuated Salmonella enterica serovar Typhimurium induces protection against a Trypanosoma cruzi lethal challenge.

Authors:  Marina N Matos; Silvia I Cazorla; Augusto E Bivona; Celina Morales; Carlos A Guzmán; Emilio L Malchiodi
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

3.  Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer.

Authors:  Jason C Steel; Giovanni Di Pasquale; Charmaine A Ramlogan; Vyomesh Patel; John A Chiorini; John C Morris
Journal:  Mol Ther       Date:  2013-01-08       Impact factor: 11.454

Review 4.  Technological Microbiology: Development and Applications.

Authors:  Luciana C Vitorino; Layara A Bessa
Journal:  Front Microbiol       Date:  2017-05-10       Impact factor: 5.640

Review 5.  Lactococcus lactis : A New Strategy for Vaccination.

Authors:  Maryam Azizpour; Seyyed Davood Hosseini; Parvaneh Jafari; Neda Akbary
Journal:  Avicenna J Med Biotechnol       Date:  2017 Oct-Dec

6.  In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A.

Authors:  Marcela de Azevedo; Jurgen Karczewski; François Lefévre; Vasco Azevedo; Anderson Miyoshi; Jerry M Wells; Philippe Langella; Jean-Marc Chatel
Journal:  BMC Microbiol       Date:  2012-12-19       Impact factor: 3.605

7.  Increasing versatility of the DNA vaccines through modification of the subcellular location of plasmid-encoded antigen expression in the in vivo transfected cells.

Authors:  Alicia Martinez-Lopez; Pablo García-Valtanen; María Del Mar Ortega-Villaizan; Verónica Chico; Regla María Medina-Gali; Luis Perez; Julio Coll; Amparo Estepa
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

8.  Correlation between fibronectin binding protein A expression level at the surface of recombinant lactococcus lactis and plasmid transfer in vitro and in vivo.

Authors:  Juliana F Almeida; Denis Mariat; Vasco Azevedo; Anderson Miyoshi; Alejandra de Moreno de LeBlanc; Silvina Del Carmen; Rebeca Martin; Philippe Langella; Jean-Guy LeBlanc; Jean-Marc Chatel
Journal:  BMC Microbiol       Date:  2014-09-25       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.